Skip to main navigation Skip to search Skip to main content

Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT

  • S. Masouridi-Levrat*
  • , E. Olavarria
  • , S. Iacobelli
  • , M. Aljurf
  • , E. Morozova
  • , R. Niittyvuopio
  • , H. Sengeloev
  • , P. Remenyi
  • , G. Helbig
  • , P. Browne
  • , A. Ganser
  • , A. Nagler
  • , J.A. Snowden
  • , M. Robin
  • , J. Passweg
  • , G. Van Gorkom
  • , H.L. Wallet
  • , J. Hoek
  • , H.J. Blok
  • , T. De Witte
  • N. Kroeger, P. Hayden, Y. Chalandon, I.Y. Agha
*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

INIS